NCT06856655Completed
Achieving Portal Access With Scorpion Post-Approval Study 2
A Retrospective Data Collection Evaluating Portal Vein Access Sets For Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures
Source: ClinicalTrials.gov · Last updated 4 Mar 2025
Brief summary (registry, in English)
Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 82 (actual)
- First submitted
- 17 Feb 2025
- Start date
- 1 Feb 2022
- Primary completion date
- 28 Mar 2024
- Lead sponsor
- Argon Medical Devices
- Diseases
- High blood pressure
- NCT number
- NCT06856655
What you commit to
- Study type: Observational
- Participants enrolled: 82
- From 1 Feb 2022 to the primary completion date, 28 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- TIPS procedure was not initiated and/or no portion of the kit was introduced into the vasculature
- Inaccessible medical records
Who the study is looking for
- 1\. Scorpion or Scorpion X kit introduced into the vasculature as the initial device for portal vein access
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.